Novel technology enables targeted epigenome editing
A team of researchers at Salk Institute (La Jolla, CA, USA) have developed a novel technology with the promise to model and treat epigenetic disorders.
Please sign in or register for FREE to view this content
Sign in to EpigenomicsNet
Register to EpigenomicsNet – the epigenetics and epigenomics network
EpigenomicsNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.